Borrowings (Tables)

9 Months Ended

Sep. 30, 2022

Borrowings [Abstract]

Summary Of Borrowings

	As of September 30, 2022
(Dollars in thousands)	Maturity Date	Contractual ‎Facility		Balance, ‎Gross		Balance, ‎Net(1)		Stated ‎Interest Rate	Effective ‎Interest ‎Rate
Denominated in USD
Trust Preferred Securities (US)	April 30, 2027	$	27,913	$	27,913	$	26,894	6.78%	6.78%
Bank of America Credit Facility (US)	March 6, 2023		34,500		34,500		34,445	8.75%	8.75%
Cinemas 1, 2, 3 Term Loan (US)	April 1, 2023		22,583		22,583		22,266	4.25%	4.25%
Minetta & Orpheum Theatres Loan (US)(2)	November 1, 2023		8,000		8,000		7,968	3.11%	5.15%
U.S. Corporate Office Term Loan (US)	January 1, 2027		8,741		8,741		8,677	4.64% / 4.44%	4.61%
Union Square Financing (US)(3)	May 6, 2024		55,000		43,000		42,360	9.91%	7.40%
Purchase Money Promissory Note (US)	September 18, 2024		1,514		1,514		1,514	5.00%	5.00%
Denominated in foreign currency ("FC") (4)
NAB Corporate Term Loan (AU)	December 31, 2023		65,336		65,336		65,251	4.51%	4.51%
Westpac Bank Corporate (NZ)	January 1, 2024		7,809		7,809		7,809	5.70%	5.70%
		$	231,396	$	219,396	$	217,184

(1)Net of deferred financing costs amounting to $2.2 million.

(2)The interest rate derivative associated with the Minetta & Orpheum loan provides for an effective fixed rate of 5.15%.

(3)The interest rate derivative associated with the Union Square loan provides for a maximum effective rate of 7.40%.

(4)The contractual facilities and outstanding balances of the foreign currency denominated borrowings were translated into U.S. dollars based on the applicable exchange rates as of September 30, 2022.

	As of December 31, 2021
(Dollars in thousands)	Maturity Date	Contractual ‎Facility		Balance, ‎Gross		Balance, ‎Net(1)		Stated ‎Interest ‎Rate	Effective ‎Interest ‎Rate
Denominated in USD
Trust Preferred Securities (US)	April 30, 2027	$	27,913	$	27,913	$	26,728	4.13%	4.13%
Bank of America Credit Facility (US)	March 6, 2023		39,500		39,500		39,364	5.75%	5.75%
Cinemas 1, 2, 3 Term Loan (US)	April 1, 2022		24,039		24,039		23,680	4.25%	4.25%
Minetta & Orpheum Theatres Loan (US)(2)	November 1, 2023		8,000		8,000		7,944	2.14%	5.15%
U.S. Corporate Office Term Loan (US)	January 1, 2027		8,936		8,936		8,860	4.64% / 4.44%	4.64%
Union Square Financing (US)(3)	May 6, 2024		55,000		43,000		42,002	7.00%	7.00%
Purchase Money Promissory Note (US)	September 18, 2024		2,043		2,043		2,043	5.00%	5.00%
Denominated in foreign currency ("FC") (4)
NAB Corporate Term Loan (AU)	December 31, 2023		74,052		74,052		73,900	1.82%	1.82%
Westpac Bank Corporate (NZ)	January 1, 2024		9,465		9,465		9,465	3.45%	3.45%
Total		$	248,948	$	236,948	$	233,986

(1)Net of deferred financing costs amounting to $3.0 million.

(2)The interest rate derivative associated with the Minetta & Orpheum loan provides for an effective fixed rate of 5.15%.

(3)The interest rate derivative associated with the Union Square loan provides for an effective fixed rate of 7.00%.

(4)The contractual facilities and outstanding balances of the foreign currency denominated borrowings were translated into U.S. dollars based on the applicable exchange rates as of December 31, 2021.

Schedule Of Long-term Debt Instruments, Net Of The Deferred Financing Costs

	September 30,		December 31,
Balance Sheet Caption (Dollars in thousands)	2022		2021
Debt - current portion	$	57,207	$	11,349
Debt - long-term portion		132,345		195,198
Subordinated debt - current portion		738		711
Subordinated debt - long-term portion		26,894		26,728
Total borrowings	$	217,184	$	233,986